Pengaruh Diabetes Mellitus Pada Keberhasilan Pengobatan Tuberkulosis : Tinjauan Sistematis

Yuni Asnitasari; Rini Mutahar; Rafiah Maharani Pulungan

doi:10.31004/koloni.v5i3.1433

Authors

Yuni Asnitasari Universitas Sriwijaya
Rini Mutahar Universitas Sriwijaya
Rafiah Maharani Pulungan Universitas Sriwijaya

DOI:

https://doi.org/10.31004/koloni.v5i3.1433

Keywords:

tuberculosis; diabetes mellitus; treatment outcomes; comorbidity; mortality.

Abstract

Tuberculosis (TB) and diabetes mellitus (DM) are major public health problems that can influence each other and affect treatment outcomes. Diabetes can impair immune function, reducing the body's ability to control Mycobacterium tuberculosis infection and potentially reducing the effectiveness of TB treatment. This systematic review aimed to examine the impact of DM on TB treatment outcomes. The review followed the PRISMA 2020 guidelines and searched PubMed, Scopus, and ScienceDirect for studies published between 2020 and 2025. Studies involving adults with active TB, with or without DM, and reporting at least one treatment outcome were included. Of 1,429 records identified, 13 observational studies met the inclusion criteria. Overall, patients with TB and DM tended to have more severe disease, more extensive pulmonary lesions, delayed sputum smear conversion, and higher risks of treatment failure, relapse, and mortality compared with patients without DM. Poor glycemic control was also associated with less favorable treatment outcomes. Several studies suggested that interventions such as therapeutic drug monitoring and adjunctive therapies may improve treatment response. These findings indicate that DM is an important comorbidity that can negatively affect TB treatment outcomes. Integrated management of TB and DM, early detection of diabetes, and optimal glycemic control are important to improve treatment success.

References

Adane, H. T., Howe, R. C., Wassie, L., & Magee, M. J. (2023). Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 31(April), 100368. https://doi.org/10.1016/j.jctube.2023.100368

Ahmad, S. R., Yaacob, N. A., Jaeb, M. Z., Hussin, Z., & Wan Mohammad, W. M. Z. (2020). Effect of diabetes mellitus on tuberculosis treatment outcomes among tuberculosis patients in Kelantan, Malaysia. Iranian Journal of Public Health, 49(8), 1485–1493. https://doi.org/10.18502/ijph.v49i8.3892

Alkabab, Y., Warkentin, J., Cummins, J., Katz, B., Denison, B. M., Bartok, A., Khalil, A., Young, L. R., Timme, E., Peloquin, C. A., Ashkin, D., Houpt, E. R., & Heysell, S. K. (2023). Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus. International Journal of Tuberculosis and Lung Disease, 27(2), 135–139. https://doi.org/10.5588/ijtld.22.0448

Amri, S. Al, Singh, J., Balushi, L. Al, Ghafri, T. Al, Balushi, M. N. Al, Marbouai, H. Al, Dhuhli, K. S. Al, Nairi, K. K. Al, Badi, M. S. Al, Mujaini, S. M. Al, & Abd-Ellatif, E. E. (2023). Prevalence and Associated Factors of Diabetes Mellitus Type 2 Among Tuberculosis Patients in Muscat, Oman, 2017–2020. Oman Medical Journal, 38(4), 2017–2020. https://doi.org/10.5001/omj.2023.82

Dashuki, A. R., Ruzlin, A. N. M., Zamzuri, M. A. I. A., & Wee, C. X. (2025). Proportions and determinants of successful tuberculosis treatment among tuberculosis patients with comorbidity registered in National Tuberculosis Registry in Negeri Sembilan from year 2018-2023. Medical Journal of Malaysia, 80(1), 50–59. https://pubmed.ncbi.nlm.nih.gov/39812429/

El-Kady, R. A. E. H., & Turkistani, S. A. (2021). The Footprint of Diabetes Mellitus on the Characteristics and Response to Anti-Tuberculous Therapy in Patients with Pulmonary Tuberculosis from Saudi Arabia. Infection and Drug Resistance, 14, 5303–5312. https://doi.org/10.2147/IDR.S344703

Houck, K., Chakhaia, T., Gorvetzian, S., Critchley, J. A., Schechter, M. C., & Magee, M. J. (2023). Diabetes Mellitus and Tuberculosis Treatment Outcomes: Interaction Assessment Between Hyperglycemia and Human Immunodeficiency Virus in the State of Georgia, 2015–2020. Open Forum Infectious Diseases, 10(6), 1–9. https://doi.org/10.1093/ofid/ofad255

Kim, K. H., Kim, H. W., Kim, Y. H., Park, Y., Jung, S. S., Kim, J. W., Oh, J. Y., Lee, H., Kim, S. K., Kim, S. H., Lyu, J., Ko, Y., Kwon, S. J., Jeong, Y. J., Kim, D. J., Koo, H. K., Jegal, Y., Kyung, S. Y., Lee, S. S., … Min, J. (2024). Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis. Respirology, 29(7), 624–632. https://doi.org/10.1111/resp.14714

Lesnic, E., Malic, A., & Tafuni, O. (2021). The impact of diabetes mellitus on the antituberculosis treatment outcome: a series of cases from the Republic of Moldova. Medicine and Pharmacy Reports, 94(3), 325–332. https://doi.org/10.15386/MPR-1974

Meng, X., Zheng, H., Du, J., Wang, X., Wang, Y., Hu, J., Zhao, J., Du, Q., & Gao, Y. (2024). Interaction of Glycemic Control and Statin Use on Diabetes-Tuberculosis Treatment Outcome: A Nested Case-Control Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2024. https://doi.org/10.1155/2024/8675248

Omar, N., Wong, J., Thu, K., Alikhan, M. F., & Chaw, L. (2021). Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Brunei Darussalam: A 6-year retrospective cohort study. International Journal of Infectious Diseases, 105, 267–273. https://doi.org/10.1016/j.ijid.2021.02.064

Sonaki, H. M., Ranpariya, P. N., & Chudasama, R. K. (2022). Health Status and Treatment Outcome of Tuberculosis with Diabetes Mellitus Cases, Rajkot City, Gujarat – A Longitudinal Study. Indian Journal of Community Medicine, 42(1), 147–150. https://doi.org/10.4103/ijcm.IJCM

Tong, F., Lai, J., Lu, Z., Bao, Z., & Cao, J. (2024). Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM. Frontiers in Medicine, 11(June), 1–8. https://doi.org/10.3389/fmed.2024.1386124

Villalva-Serra, K., Barreto-Duarte, B., Nunes, V. M., Menezes, R. C., Rodrigues, M. M. S., Queiroz, A. T. L., Arriaga, M. B., Cordeiro-Santos, M., Kritski, A. L., Sterling, T. R., Araújo-Pereira, M., & Andrade, B. B. (2022). Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.972145

Zhu, Y., Forsman, L. D., Chen, C., Zhang, H., Shao, G., Wang, S., Wang, S., Xiong, H., Bruchfeld, J., Wang, W., Zhu, L., Alffenaar, J. W., & Hu, Y. (2024). Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China. Clinical Infectious Diseases, 79(2), 524–533. https://doi.org/10.1093/cid/ciae329